Literature DB >> 24907214

Acute hepatitis C infection in a renal transplant recipient: primacy of the liver or kidney?

Mohammed Mahdi Althaf1, Mohamed Said Abdelsalam2, Mohamed Rashwan1, Quaid Nadri1.   

Abstract

We present a case where a renal transplant recipient contracted chronic hepatitis C virus (HCV) infection post-transplantation. The disease progressed and deteriorated leading to fibrosing cholestatic hepatitis that mandated treatment. Treatment with pegylated interferon α-2a and ribavirin was successful in salvaging the liver and eradicating the virus but as a consequence lead to treatment-resistant acute rejection and loss of the renal allograft. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24907214      PMCID: PMC4054393          DOI: 10.1136/bcr-2014-203643

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients.

Authors:  Kuo-Hsiung Shu; Joung-Liang Lan; Ming-Ju Wu; Chi-Hung Cheng; Chen-Hsu Chen; Wen-Chin Lee; Horng-Rong Chang; Jong-Da Lian
Journal:  Transplantation       Date:  2004-06-27       Impact factor: 4.939

3.  Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients.

Authors:  F Fabrizi; G Lunghi; V Dixit; P Martin
Journal:  Aliment Pharmacol Ther       Date:  2006-11-15       Impact factor: 8.171

4.  KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.

Authors: 
Journal:  Kidney Int Suppl       Date:  2008-04       Impact factor: 10.545

Review 5.  The Declaration of Istanbul: review and commentary by the American Society of Transplant Surgeons Ethics Committee and Executive Committee.

Authors:  A I Reed; R M Merion; J P Roberts; G B Klintmalm; M M Abecassis; K M Olthoff; A N Langnas
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

Review 6.  Global initiatives to tackle organ trafficking and transplant tourism.

Authors:  Alireza Bagheri; Francis L Delmonico
Journal:  Med Health Care Philos       Date:  2013-11

7.  The impact of transplantation with deceased donor hepatitis c-positive kidneys on survival in wait-listed long-term dialysis patients.

Authors:  Kevin C Abbott; Krista L Lentine; Jay R Bucci; Lawrence Y Agodoa; Thomas G Peters; Mark A Schnitzler
Journal:  Am J Transplant       Date:  2004-12       Impact factor: 8.086

8.  Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C.

Authors:  Faisal M Sanai; Dujana Mousa; Abdallah Al-Mdani; Ghada Al-Shoail; Hamad Al-Ashgar; Khalid Al Meshari; Ahmed Al-Qahtani; Mayssa Saadeh; Khalid I Bzeizi; Hassan Aleid
Journal:  J Hepatol       Date:  2013-02-18       Impact factor: 25.083

9.  Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation.

Authors:  K G Benner; R G Lee; E B Keeffe; R R Lopez; A W Sasaki; C W Pinson
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

10.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

View more
  3 in total

Review 1.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Roberto J Carvalho-Filho; Ana Cristina C A Feldner; Antonio Eduardo B Silva; Maria Lucia G Ferraz
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

2.  Fibrosing cholestatic hepatitis in a kidney transplant recipient with hepatitis C virus.

Authors:  Takahiro Shinzato; Taro Kubo; Toshihiro Shimizu; Koji Nanmoku; Takashi Yagisawa
Journal:  CEN Case Rep       Date:  2019-01-02

Review 3.  Hepatitis C Virus Infection in Chronic Kidney Disease.

Authors:  Marco Ladino; Fernando Pedraza; David Roth
Journal:  J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 10.121

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.